Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 23Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Regulatory requirements for marketing fixed dose combinations

Jayasheel B G

Year : 2010| Volume: 1| Issue : 4 | Page no: 120-123

   This article has been cited by
1 Formulation development and evaluation of bi layer tablets: a fixed dose combination of sumatriptan succinate and naproxen sodium as immediate release layer and sumatriptan succinate as delayed release layer
Poluri Koteswari,Srinivasa Babu Puttugunta,Gangadhar Vadlatala
Journal of Pharmaceutical Investigation. 2014;
[Pubmed]  [Google Scholar] [DOI]


Read this article